drugset
drugset / Trial / NCT00006799

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

NCT00006799 ↗

Phase 3 Completed 13 enrolled Wake Forest University Health Sciences National Cancer Institute (NCI) · collab
RandomizedDouble-blindSupportive care

Summary

RATIONALE: Megestrol helps improve appetite. It is not yet known if megestrol is effective in limiting weight loss caused by cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in limiting weight loss and improving quality of life in patients who have head and neck cancer and are undergoing radiation therapy.

Timeline

Start
2000-10-01
Primary completion
2002-09-06
Completion
2002-09-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified — Oral

Indications

eating disorder head and neck cancer